(Q38285042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

review article

1 reference

title

Valproic acid-mediated neuroprotection and neurogenesis after spinal cord injury: from mechanism to clinical potential (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Tianci Chu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Hengxing Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Lu Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Xiaohong Kong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bin Pan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Shiqing Feng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

8 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

published in

Regenerative Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

193-209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

Pharmacological interventions for spinal cord injury: where do we stand? How might we step forward?

24 February 2020

cites work

1 reference

Pathophysiology and pharmacologic treatment of acute spinal cord injury

21 January 2018

1 reference

Therapeutic interventions after spinal cord injury.

21 January 2018

1 reference

Adult neurogenesis in the mammalian central nervous system

21 January 2018

1 reference

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder

21 January 2018

1 reference

Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries

21 January 2018

1 reference

Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury.

21 January 2018

1 reference

Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro

21 January 2018

1 reference

Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition

21 January 2018

1 reference

Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stress-mediated cytochrome C release after spinal cord injury

21 January 2018

1 reference

Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells

21 January 2018

1 reference

The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells

21 January 2018

1 reference

Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.

21 January 2018

1 reference

Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.

21 January 2018

1 reference

Molecular and therapeutic potential and toxicity of valproic acid

21 January 2018

1 reference

Distribution of valproate across the interface between blood and cerebrospinal fluid

21 January 2018

1 reference

Sodium valproate: an old drug with new roles

21 January 2018

1 reference

Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon

21 January 2018

1 reference

Review of current evidence for apoptosis after spinal cord injury.

21 January 2018

1 reference

Multiple roles of HDAC inhibition in neurodegenerative conditions.

21 January 2018

1 reference

Valproate reduces CHOP levels and preserves oligodendrocytes and axons after spinal cord injury.

21 January 2018

1 reference

The neuroprotective effect of treatment of valproic Acid in acute spinal cord injury

21 January 2018

1 reference

Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury

21 January 2018

1 reference

Valproic acid reduces autophagy and promotes functional recovery after spinal cord injury in rats

21 January 2018

1 reference

Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia

21 January 2018

1 reference

Valproic Acid increases expression of neuronal stem/progenitor cell in spinal cord injury

21 January 2018

1 reference

Valproic acid inhibits neural progenitor cell death by activation of NF-κB signaling pathway and up-regulation of Bcl-XL.

21 January 2018

1 reference

Induction of autophagy and autophagic cell death in damaged neural tissue after acute spinal cord injury in mice.

21 January 2018

1 reference

The role of autophagy in spinal cord injury

21 January 2018

1 reference

Systemic bisperoxovanadium activates Akt/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury

21 January 2018

1 reference

Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury

21 January 2018

1 reference

Spinal cord injury induces early and persistent lesional P2X4 receptor expression.

21 January 2018

1 reference

Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity

21 January 2018

1 reference

Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia.

21 January 2018

1 reference

Histone deacetylase inhibitors are neuroprotective and preserve NGF-mediated cell survival following traumatic brain injury

21 January 2018

1 reference

The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system.

21 January 2018

1 reference

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

21 January 2018

1 reference

Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation

21 January 2018

1 reference

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

Production of superoxide anions by a CNS macrophage, the microglia.

21 January 2018

1 reference

Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function.

21 January 2018

1 reference

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

21 January 2018

1 reference

Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition

21 January 2018

1 reference

Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation

21 January 2018

1 reference

Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway

21 January 2018

1 reference

Neural stem cells for spinal cord repair.

21 January 2018

1 reference

Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord

21 January 2018

1 reference

Mechanisms of neural stem cell fate determination: extracellular cues and intracellular programs

21 January 2018

1 reference

Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries

21 January 2018

1 reference

HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation

21 January 2018

1 reference

The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth

21 January 2018

1 reference

Neurotrophin signalling and transcription programmes interactions in the development of somatosensory neurons

21 January 2018

1 reference

21 January 2018

1 reference

The Wnt/beta-catenin signaling pathway as a target in drug discovery

21 January 2018

1 reference

The glamour and gloom of glycogen synthase kinase-3

21 January 2018

1 reference

Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin--developmental effects of valproic acid

21 January 2018

1 reference

Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors

21 January 2018

1 reference

Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis.

21 January 2018

1 reference

WNTs in the vertebrate nervous system: from patterning to neuronal connectivity

21 January 2018

1 reference

Neurogenesis and neuroprotection in the CNS--fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders

21 January 2018

1 reference

Profile of spinal injuries in Lagos, Nigeria

21 January 2018

1 reference

Changes occur in the ability to promote axonal regeneration as the post-injury period increases.

21 January 2018

1 reference

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures

21 January 2018

1 reference

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design

21 January 2018

1 reference

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics

21 January 2018

1 reference

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

21 January 2018

1 reference

The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/RME.14.86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25485637%20AND%20SRC:MED&resulttype=core&format=json